Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Publications indexed to the term Interleukins

FacultyTitle
1Mitochondrial DNA oxidation propagates autoimmunity by enabling plasmacytoid dendritic cells to induce TFH differentiation. (Xian H, Watari K, Ohira M, Brito JS, He P, Onyuru J, Zuniga EI, Hoffman HM, Karin M) Nat Immunol 2025 Jul;26(7):1168-1181       5 Citations
3Intestinal epithelium-derived IL-34 reprograms macrophages to mitigate gastrointestinal tract graft-versus-host disease. (Rayasam A, Moe A, Kudek M, Shah RK, Yuan CY, Miller JM, Rau M, Patton M, Wanat K, Colonna M, Zamora AE, Drobyski WR) Sci Transl Med 2025 Feb 12;17(785):eadn3963       3 Citations
1IL-27 promotes pathogenic T cells in a mouse model of Sjögren's disease. (Debreceni IL, Barr JY, Upton EM, Chen YG, Lieberman SM) Clin Immunol 2024 Jul;264:110260       1 Citation
1Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease. (Bastian D, Sui X, Nguyen HD, Wu Y, Schutt S, Tian L, Sofi MH, Liu Y, Martin P, Bartee E, Yu XZ) Am J Transplant 2021 Nov;21(11):3538-3549       12 Citations
1Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice. (Allred MG, Chimenti MS, Ciecko AE, Chen YG, Lieberman SM) Int J Mol Sci 2021 Apr 05;22(7)       11 Citations
1Differential Expression of Cytokine-Coding Genes among Migraine Patients with and without Aura and Normal Subjects. (Taheri M, Nicknafs F, Hesami O, Javadi A, Arsang-Jang S, Sayad A, Ghafouri-Fard S) J Mol Neurosci 2021 Jun;71(6):1197-1204       15 Citations
1Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study. (Gadalla SM, Wang Y, Wang T, Onabajo OO, Banday AR, Obajemu A, Karaesman E, Sucheston-Campbell L, Hahn T, Sees JA, Spellman SR, Lee SJ, Katki HA, Prokunina-Olsson L) Lancet Haematol 2020 Oct;7(10):e715-e723       11 Citations
1Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2. (DelGiorno KE, Chung CY, Vavinskaya V, Maurer HC, Novak SW, Lytle NK, Ma Z, Giraddi RR, Wang D, Fang L, Naeem RF, Andrade LR, Ali WH, Tseng H, Tsui C, Gubbala VB, Ridinger-Saison M, Ohmoto M, Erikson GA, O'Connor C, Shokhirev MN, Hah N, Urade Y, Matsumoto I, Kaech SM, Singh PK, Manor U, Olive KP, Wahl GM) Gastroenterology 2020 Nov;159(5):1866-1881.e8       64 Citations
2Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like Inflammation. (Ciecko AE, Foda B, Barr JY, Ramanathan S, Atkinson MA, Serreze DV, Geurts AM, Lieberman SM, Chen YG) Cell Rep 2019 Dec 03;29(10):3073-3086.e5       48 Citations
1Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study. (Gordon KB, Armstrong AW, Foley P, Song M, Shen YK, Li S, Muñoz-Elías EJ, Branigan P, Liu X, Reich K) J Invest Dermatol 2019 Dec;139(12):2437-2446.e1       92 Citations
1IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection. (Kumar P, Rajasekaran K, Nanbakhsh A, Gorski J, Thakar MS, Malarkannan S) Sci Rep 2019 Mar 21;9(1):4984       24 Citations
2Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection. (Xin G, Zander R, Schauder DM, Chen Y, Weinstein JS, Drobyski WR, Tarakanova V, Craft J, Cui W) Nat Commun 2018 Nov 28;9(1):5037       71 Citations
1B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation. (Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O'Reilly RJ, Notarangelo LD, Pai SY) Blood 2018 Jun 28;131(26):2967-2977       38 Citations
1IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB. (Victor AR, Nalin AP, Dong W, McClory S, Wei M, Mao C, Kladney RD, Youssef Y, Chan WK, Briercheck EL, Hughes T, Scoville SD, Pitarresi JR, Chen C, Manz S, Wu LC, Zhang J, Ostrowski MC, Freud AG, Leone GW, Caligiuri MA, Yu J) J Immunol 2017 Oct 01;199(7):2333-2342       79 Citations
1Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. (Rosen MJ, Karns R, Vallance JE, Bezold R, Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams JS, Baker SS, Kellermayer R, Noe JD, Griffiths AM, Rosh JR, Crandall WV, Heyman MB, Mack DR, Kappelman MD, Markowitz J, Moulton DE, Leleiko NS, Walters TD, Kugathasan S, Wilson KT, Hogan SP, Denson LA) Gastroenterology 2017 May;152(6):1345-1357.e7       63 Citations
1Alterations in macrophage phenotypes in experimental venous thrombosis. (Gallagher KA, Obi AT, Elfline MA, Hogikyan E, Luke CE, Henke S, Coleman D, Henke PK) J Vasc Surg Venous Lymphat Disord 2016 Oct;4(4):463-71       26 Citations
2Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression. (Belle L, Agle K, Zhou V, Yin-Yuan C, Komorowski R, Eastwood D, Logan B, Sun J, Ghilardi N, Cua D, Williams CB, Gaignage M, Marillier R, van Snick J, Drobyski WR) Blood 2016 Oct 20;128(16):2068-2082       38 Citations
1Conventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells. (Korn LL, Thomas HL, Hubbeling HG, Spencer SP, Sinha R, Simkins HM, Salzman NH, Bushman FD, Laufer TM) Mucosal Immunol 2014 Sep;7(5):1045-57       71 Citations
1Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. (Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, Noel RJ, Verbsky JW, Freeman AF, Janssen E, Bonilla FA, Pechacek J, Chandrasekaran P, Browne SK, Agharahimi A, Gharib AM, Mannurita SC, Yim JJ, Gambineri E, Torgerson T, Tran DQ, Milner JD, Holland SM) J Allergy Clin Immunol 2013 Jun;131(6):1611-23       278 Citations
1CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis. (Takekoshi T, Wu X, Mitsui H, Tada Y, Kao MC, Sato S, Dwinell MB, Hwang ST) J Invest Dermatol 2013 Nov;133(11):2530-2537       24 Citations
1Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. (Durrani SR, Montville DJ, Pratt AS, Sahu S, DeVries MK, Rajamanickam V, Gangnon RE, Gill MA, Gern JE, Lemanske RF Jr, Jackson DJ) J Allergy Clin Immunol 2012 Aug;130(2):489-95       221 Citations
1IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. (Kumar P, Thakar MS, Ouyang W, Malarkannan S) Mucosal Immunol 2013 Jan;6(1):69-82       163 Citations
1Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat. (Kaldunski M, Jia S, Geoffrey R, Basken J, Prosser S, Kansra S, Mordes JP, Lernmark A, Wang X, Hessner MJ) Diabetes 2010 Oct;59(10):2375-85       27 Citations
1IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. (Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, Alysandratos KD, Kalogeromitros D, Asadi S, Stavrianeas N, Peterson E, Leeman S, Conti P) Proc Natl Acad Sci U S A 2010 Mar 02;107(9):4448-53       303 Citations
1Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. (Leath CA 3rd, Kataram M, Bhagavatula P, Gopalkrishnan RV, Dent P, Fisher PB, Pereboev A, Carey D, Lebedeva IV, Haisma HJ, Alvarez RD, Curiel DT, Mahasreshti PJ) Gynecol Oncol 2004 Aug;94(2):352-62       26 Citations
1Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors. (Joseph BZ, Routes JM, Borish L) Inflammation 1993 Jun;17(3):361-70       42 Citations
1Constitutive and induced expression of growth factors in normal and chronic phase chronic myelogenous leukemia Ph1 bone marrow stroma. (Wetzler M, Kurzrock R, Taylor K, Spitzer G, Kantarjian H, Baiocchi G, Ku S, Gutterman JU, Talpaz M) Cancer Res 1990 Sep 15;50(18):5801-5       27 Citations